Richard Sassun M.D. (@richardsassun) 's Twitter Profile
Richard Sassun M.D.

@richardsassun

Colorectal Surgery Fellow at Mayo Clinic Rochester

General surgery resident in the Colorectal Division of Istituto Nazionale dei Tumori

ID: 340272184

calendar_today22-07-2011 12:36:34

59 Tweet

111 Takipçi

122 Takip Edilen

STITCHES - the Best Papers in General Surgery (@stitchestoday) 's Twitter Profile Photo

Young Age Linked to Higher Cancer Treatment Success by Sileo A, Sassun R (...) Larson DW et 7 al. in Ann Surg Oncol 🪡 read our summary 👉 stitches.today/2025/01/22/you… 📖 read the article: link.springer.com/article/10.124…

Richard Sassun M.D. (@richardsassun) 's Twitter Profile Photo

Rectal cancers with no response to TNT exhibit the worst survival outcomes. What features can predict a no response to TNT? 🤔 Find out in our recent article on Annals of Surgical Oncology!!! 👇👇👇 link.springer.com/article/10.124… Jyi Cheng Ng Annaclara Sileo

Richard Sassun M.D. (@richardsassun) 's Twitter Profile Photo

Diverticular colovaginal/vesical fistulas represent a difficult scenario for surgeons. In laparoscopy, 36% of cases are converted🔪 Our study found that robotic surgery yields a 1% conversion rate and recurrence! 🤖 Jyi Cheng Ng David Larson, MD MBA Annaclara Sileo pubmed.ncbi.nlm.nih.gov/40355739/

American College of Surgeons (@amcollsurgeons) 's Twitter Profile Photo

A recent study has concluded that if current practices continue, CT related cancers will be 5% of the annual cancer diagnoses in the US. The authors used CT imaging data from 2018–2020 to estimate the risk of radiation-induced cancer. ACS Cancer Programs brnw.ch/21wSIm9

Mustafa Özdoğan, MD (@ozdogan_md) 's Twitter Profile Photo

🚨 Exercise is no longer optional, it is essential! One of the most impactful studies at #ASCO25 🏃‍♂️ The #CHALLENGE trial (LBA4319) proves that structured exercise after chemo in stage III colon cancer is not just lifestyle—it’s life-saving. 📊 5y DFS: 80.3% vs 73.9% ❤️ 8y OS:

🚨 Exercise is no longer optional, it is essential!

One of the most impactful studies at #ASCO25

🏃‍♂️ The #CHALLENGE trial (LBA4319) proves that structured exercise after chemo in stage III colon cancer is not just lifestyle—it’s life-saving.

📊 5y DFS: 80.3% vs 73.9%
❤️ 8y OS:
Richard Sassun M.D. (@richardsassun) 's Twitter Profile Photo

Diverticulitis' incidence is rising, but surgery is not always recommended, especially for uncomplicated cases. We delved into the relationship of surgery, quality of life, and cytokine levels, revealing a benefit with surgery. Read the full paper here!🔥 onlinelibrary.wiley.com/doi/10.1111/co…

Diverticulitis' incidence is rising, but surgery is not always recommended, especially for uncomplicated cases. 
We delved into the relationship of surgery, quality of life, and cytokine levels, revealing a benefit with surgery.
Read the full paper here!🔥
onlinelibrary.wiley.com/doi/10.1111/co…
Richard Sassun M.D. (@richardsassun) 's Twitter Profile Photo

Great news!🔥 In our new RCTs Metanalysis, OS and DFS were improved with Neoadjuvant Chemotherapy compared to Adjuvant Chemotherapy 🔎Trial sequential analysis confirms that the evidence is conclusive. No further RCTs are needed! Link tinyurl.com/2ampyynj David Larson, MD MBA Isacco Montroni

OncoDaily GI (@oncodailygi) 's Twitter Profile Photo

New Meta-Analysis on Neoadjuvant Chemotherapy in Colon Cancer from Mayo Clinic - Christopher Williams Richard Sassun M.D. | David Larson, MD MBA | Eric J. Dozois | Isacco Montroni oncodaily.com/insight/neoadj… #Cancer #ColonCancer #MayoClinic #MedEd #MedX #NeoadjuvantChemotherapy #OncoDaily #Oncology

New Meta-Analysis on Neoadjuvant Chemotherapy in Colon Cancer from Mayo Clinic - Christopher Williams
<a href="/RichardSassun/">Richard Sassun M.D.</a> | <a href="/DrDavidLarson/">David Larson, MD MBA</a> | <a href="/EricDozoisMD/">Eric J. Dozois</a> | <a href="/3isac/">Isacco Montroni</a> 

oncodaily.com/insight/neoadj…

#Cancer #ColonCancer #MayoClinic #MedEd #MedX #NeoadjuvantChemotherapy #OncoDaily #Oncology
STITCHES - the Best Papers in General Surgery (@stitchestoday) 's Twitter Profile Photo

Neoadjuvant chemotherapy enhances survival rates in colon cancer by Sassun R, Sileo A (...) Larson DW et 5 al. in Ann Surg Oncol 🪡 read our summary 👉 stitches.today/2025/06/25/neo… 📖 read the article: link.springer.com/article/10.124…

Mayo Clinic Department of Surgery (@mayoclinicsurg) 's Twitter Profile Photo

A study led by Mayo Clinic surgeons shows total neoadjuvant therapy followed by surgery to treat advanced #RectalCancer leads to excellent outcomes, including low recurrence and a high percentage of cancer-specific survival. Read the study to learn more: bit.ly/3ZYAakN

A study led by <a href="/MayoClinic/">Mayo Clinic</a> surgeons shows total neoadjuvant therapy followed by surgery to treat advanced #RectalCancer leads to excellent outcomes, including low recurrence and a high percentage of cancer-specific survival. Read the study to learn more: bit.ly/3ZYAakN
Ibrahim Gomaa, MD (@ibrahim_gomaa95) 's Twitter Profile Photo

📣📣Excited to share our publication in Annals of Surgical Oncology on the impact of RAS/BRAF mutations on pCR in rectal cancer in the TNT era. 🟢 Mutations associated with: ⬇️ pCR rates ⬇️ DFS Grateful to David Larson, MD MBA and all co-authors! Richard Sassun M.D. Jyi Cheng Ng, MD Mayo Clinic Department of Surgery

📣📣Excited to share our publication in <a href="/AnnSurgOncol/">Annals of Surgical Oncology</a> on the impact of RAS/BRAF mutations on pCR in rectal cancer in the TNT era.

🟢 Mutations associated with:
⬇️ pCR rates
⬇️ DFS

Grateful to <a href="/DrDavidLarson/">David Larson, MD MBA</a> and all co-authors! <a href="/RichardSassun/">Richard Sassun M.D.</a> <a href="/JyiChengNg/">Jyi Cheng Ng, MD</a> <a href="/MayoClinicSurg/">Mayo Clinic Department of Surgery</a>
Mayo Clinic Department of Surgery (@mayoclinicsurg) 's Twitter Profile Photo

A study led by Mayo Clinic clinicians shows that neoadjuvant chemotherapy (NAC) improves 5-year survival in locally advanced #ColonCancer. Analysis of 8 control trials supports NAC as a safe, effective alternative with high-quality evidence. Learn more: bit.ly/4mhoTVB

A study led by <a href="/MayoClinic/">Mayo Clinic</a> clinicians shows that neoadjuvant chemotherapy (NAC) improves 5-year survival in locally advanced #ColonCancer. Analysis of 8 control trials supports NAC as a safe, effective alternative with high-quality evidence. Learn more: bit.ly/4mhoTVB